Selected highlights from ECTRIMS 2018
Berlin, Germany – 10-12 October 2018
36 slides
Scientific review:
Dr. Daniel Selchen, Senior Consultant, Division of Neurology, St. Michael’s Hospital, Toronto, Canada
Key topics featured
• Guidelines – Revised McDonald criteria and their impact on diagnosis
• Biomarkers – Neurofilament-light protein, central vein sign
• Myelocortical MS
• Gut microbiome
• Environmental risk factors (vitamin D, obesity)
• Disease-modifying therapies in RRMS and progressive MS
• Safety (pregnancy, ocrelizumab)
• Initiating/Switching/Discontinuing DMDs
• “Abdominal Lhermitte’s” and other clinical observations
• Physician/patient perceptions
All slides developed by NeuroSens in collaboration with Dr. Daniel Selchen
The slide deck is open access, and no permissions are required prior to use. As a courtesy, we would like to ask that you provide us with feedback after your presentation(s). This will help us to fine-tune free educational resources that NeuroSens develops in the future.
Click here to complete the feedback questionnaire